Syneos Health to Acquire Synteract, Expand Its Global Expertise

Syneos Health announced on Wednesday that it has agreed to acquire Synteract, a full-service Contract Research Organization (CRO) focused on the biopharmaceutical industry. Synteract has therapeutic expertise in oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics. Its 700 employees have supported more than 4,000 clinical trials across 26,000 sites in approximately 60 countries.